Logs: Bang Zheng
The following is a list of all job requests run via OpenSAFELY by Bang Zheng.
| Status | Organisation | Project | Workspace | Request ID | Backend | Jobs | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14201 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 16:29:17 UTC | View, Job request 14201 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14195 | TPP | 2/2 | 3 years, 2 months ago 03 January 2023 13:28:19 UTC | View, Job request 14195 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14194 | TPP | 1/1 | 3 years, 2 months ago 03 January 2023 13:14:34 UTC | View, Job request 14194 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14192 | TPP | 1/2 | 3 years, 2 months ago 03 January 2023 10:58:43 UTC | View, Job request 14192 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14188 | TPP | 1/2 | 3 years, 2 months ago 02 January 2023 22:01:03 UTC | View, Job request 14188 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14177 | TPP | 2/2 | 3 years, 2 months ago 28 December 2022 11:34:19 UTC | View, Job request 14177 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14176 | TPP | 1/2 | 3 years, 2 months ago 27 December 2022 22:55:14 UTC | View, Job request 14176 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14175 | TPP | 1/2 | 3 years, 2 months ago 27 December 2022 21:59:09 UTC | View, Job request 14175 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14174 | TPP | 2/2 | 3 years, 2 months ago 27 December 2022 21:20:26 UTC | View, Job request 14174 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14173 | TPP | 1/1 | 3 years, 2 months ago 27 December 2022 21:04:25 UTC | View, Job request 14173 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14159 | TPP | 1/1 | 3 years, 2 months ago 22 December 2022 16:08:38 UTC | View, Job request 14159 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14137 | TPP | 1/2 | 3 years, 2 months ago 21 December 2022 12:01:52 UTC | View, Job request 14137 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14135 | TPP | 2/2 | 3 years, 2 months ago 21 December 2022 11:14:26 UTC | View, Job request 14135 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14131 | TPP | 2/2 | 3 years, 2 months ago 20 December 2022 19:14:20 UTC | View, Job request 14131 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14130 | TPP | 2/2 | 3 years, 2 months ago 20 December 2022 19:04:43 UTC | View, Job request 14130 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 14129 | TPP | 2/2 | 3 years, 2 months ago 20 December 2022 18:40:28 UTC | View, Job request 14129 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13889 | TPP | 1/1 | 3 years, 2 months ago 12 December 2022 21:10:05 UTC | View, Job request 13889 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13779 | TPP | 2/2 | 3 years, 3 months ago 06 December 2022 16:39:46 UTC | View, Job request 13779 |
| Succeeded | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13768 | TPP | 1/1 | 3 years, 3 months ago 06 December 2022 15:27:49 UTC | View, Job request 13768 |
| Failed | Bennett Institute | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 13767 | TPP | 0/1 | 3 years, 3 months ago 06 December 2022 13:44:08 UTC | View, Job request 13767 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13635 | TPP | 1/1 | 3 years, 3 months ago 30 November 2022 17:02:23 UTC | View, Job request 13635 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13628 | TPP | 1/1 | 3 years, 3 months ago 30 November 2022 14:58:36 UTC | View, Job request 13628 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13624 | TPP | 1/1 | 3 years, 3 months ago 30 November 2022 14:07:06 UTC | View, Job request 13624 |
| Failed | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13616 | TPP | 1/2 | 3 years, 3 months ago 30 November 2022 13:16:03 UTC | View, Job request 13616 |
| Succeeded | The London School of Hygiene & Tropical Medicine | Effectiveness safety sotrovimab molnupiravir | sotrovimab_molnupiravir | 13614 | TPP | 1/1 | 3 years, 3 months ago 30 November 2022 10:51:14 UTC | View, Job request 13614 |